Wollastonite
Based on 1 Customer Validation
Wollastonite is a white, chain-structured pyroxene silicate mineral with biocompatibility, biodegradability, osteogenicity and antibacterial properties. Wollastonite induces transient pulmonary inflammatory responses, reversible alveolar macrophage responses, early inflammatory/proliferative mesothelial cell responses, ROS production, and mild chronic pulmonary interstitial inflammation in rats. Wollastonite induces osteogenic differentiation, promotes bone growth, supports angiogenesis, and facilitates the formation of hydroxycarbonate apatite on its surface. Wollastonite enhances the strength, bioactivity and biodegradability of hydroxyapatite scaffolds, and is used to construct porous bone tissue engineering scaffolds. Wollastonite is applied in research related to diseases such as bronchitis, decreased lung function and bone defects.
For research use only. We do not sell to patients.
- CAS No.: 13983-17-0
- Formula: CaH2O3Si
- Molecular Weight:118.18
-
Storage:
Store at room temperature, keep dry and cool.
In solvent -80°C, 1 year , -20°C, 6 months
Biological Activity
Description
In Vitro
Wollastonite exhibits higher strength than traditional porcelain in low-temperature fired ceramics (67 MPa at 1200°C), along with the characteristics of lower firing temperature, less energy consumption and self-glazing; it shows better glossiness, spreadability and whiteness in glaze formulations; in facing tile mixtures, it reduces drying/firing shrinkage and wet expansion rate, and improves deformation resistance, heat resistance and frost resistance[1].
Wollastonite exhibits significantly lower cytotoxicity towards cultured rabbit alveolar macrophages than chrysotile asbestos; it also has lower hemolytic potential and induces lower levels of lipid peroxidation in red blood cells; in cell-free deoxyribose and PMN leukocyte systems, it generates higher levels of non-hydroxyl radical reactive oxygen species than asbestos[2].
Wollastonite (10 wt%) increases the water absorption rate of PHBV scaffolds by 44.1% compared with pure PHBV scaffolds, thereby enhancing their applicability in biological applications[3].
Wollastonite coatings can form hydroxycarbonate apatite upon immersion in simulated body fluid, exhibiting in vitro bioactivity[3].
Wollastonite glass-ceramic scaffolds support the growth and adhesion of human mesenchymal stem cells, and form a fused cell layer after 21 days of osteogenic culture[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
In Vivo
Wollastonite (10 mg/m3; administered via inhalation; 6 hours per day, 5 days per week; for 12 or 24 months) induces mild interstitial fibrosis in male F344 rats, but does not increase their pulmonary tumor incidence[2].
Wollastonite (50-100 mg/m3; inhalation exposure; 6 hours per day; for 3 or 5 consecutive days) induces transient and milder pulmonary inflammatory responses in male Crl:CDBR rats compared with Crocidolite[2].
Wollastonite (25 mg; intratracheal administration; single dose) induces mild to moderate pulmonary effects in male Wistar rats[2].
Wollastonite (1 mg; intratracheal administration; single dose) induces mild, non-progressive chronic interstitial inflammation in male Sprague-Dawley rats within 6 months[2].
Wollastonite (114 mg/m3; exposed via inhalation; 6 hours per day for 5 consecutive days) has a retention half-life of less than 1 week in male Crl:CDBR rats, indicating that it can be rapidly cleared from the lungs[2].
Wollastonite-based scaffolds doped with dilute magnesium (CSi-Mgx) fabricated via 3D printing (surgical implantation; single administration) exhibit excellent strength, degradability and osteogenic capacity, rendering them promising for bone regeneration of thin-wall bone defects in rabbits[3].
Wollastonite-hydroxyapatite composite biomaterial (surgical implantation; single administration) safely enhances vascularization and promotes new bone formation at the surgical defect site of the femur in rats at 12 weeks post-implantation[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Osborne-Mendel (female, 12-20 weeks of age, intrapleural fiber-induced pleural sarcoma model)[2]
-
Dosage:40 mg/animal
-
Administration:intrapleural; single dose
-
Result:Produced variable pleural sarcoma incidence by wollastonite grade: grade 1 (25%, 5/20), grade 2 (8%, 2/25), grade 3 (14.3%, 3/21), grade 4 (0%, 0/24).
-
Animal Model:Crl:CDBR (male, short-term inhalation exposure model)[2]
-
Dosage:50, 100 mg/m3
-
Administration:inhalation; 6 hours/day; 3 or 5 days
-
Result:Produced transient pulmonary inflammatory responses and increases in BAL fluid parameters only when the mass median aerodynamic diameter (MMAD) was 2.6 μm and exposure concentration exceeded 500 fibers/mL; the severity and duration of responses were less than those induced by crocidolite.
-
Animal Model:Crl:CDBR (male, 8 weeks of age, inhalation exposure model)[2]
-
Dosage:114 mg/m3
-
Administration:inhalation; 6 hours/day; 5 days
-
Result:Cleared rapidly from the lungs, with a retention half-time of <1 week.
Chemical Information
-
CAS No. 13983-17-0
-
Appearance Solid
-
Molecular Weight 118.18
-
Formula CaH2O3Si
-
Color White to off-white
-
SMILES
[Ca][Si](O[O])=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Store at room temperature, keep dry and cool
In solvent -80°C 1 year -20°C 6 months
Protocols
-
3D Hydrogel Synthetic Scaffold Culture
3D hydrogel synthetic scaffold culture embeds cells, spheroids, organoids, or tissue fragments inside a hydrated crosslinked polymer network so that cells receive matrix and cell-cell cues in three dimensions rather than from a flat plastic surface. A literature-supported model protocol is PEG-4MAL hydrogel culture, in which four-arm maleimide-terminated PEG is functionalized with cysteine-containing adhesive peptides such as RGD and crosslinked with protease-degradable peptides such as GPQ-W; this creates a defined, modular scaffold that supports human organoid generation and culture. The readouts are scaffold-supported growth, morphology, lumen formation, budding, viability, proliferation, lineage-marker expression, and matrix-dependent expansion or differentiation; reported assays include transmitted-light imaging, immunofluorescence, in situ hybridization, qRT-PCR, and rheological characterization.
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
Human pluripotent stem cell endothelial-cell differentiation
Human pluripotent stem cell endothelial differentiation is based on stepwise developmental patterning: early activation of WNT/GSK3β inhibition promotes mesodermal or vascular progenitor entry, followed by endothelial specification using VEGF-related signaling, BMP4, FGF2, Notch modulation, or cAMP depending on the published protocol. Endothelial differentiation is read out by acquisition of CD31, CD34, VE-cadherin/CD144, KDR/VEGFR2, vWF, Tie2, NOS3, acetylated LDL uptake, tube/network formation, barrier function, and in vivo vessel-forming capacity where tested.
-
Vascular/Branching Fractal Analysis
Vascular/branching fractal analysis quantifies the geometric complexity of vessel trees or vascular networks from segmented 2D images, commonly by converting vessels into binary and/or skeletonized maps and estimating fractal dimension using box-counting or related approaches. Fractal dimension is interpreted as an image-derived readout of vascular branching complexity, space filling, or density, and has been applied to retinal photographs, fluorescein angiography, OCT angiography, capillary perfusion maps, and in vitro Matrigel angiogenesis networks. The assay readout is generated from vessel-positive pixels after image preprocessing, vessel segmentation, binarization, and optional skeletonization; reported outputs include fractal dimension, vessel density, branchpoint density, endpoint density, vessel length density, tortuosity, and generation-based branching metrics when VESGEN-style analysis is used. The biological interpretation is limited to quantitative vascular patterning and s
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
-
Mesenchymal stromal/stem cell osteogenic differentiation
Mesenchymal stromal/stem cells can be induced toward an osteoblast-like lineage in vitro by culture in osteogenic medium containing dexamethasone, ascorbic acid or ascorbate-2-phosphate, and β-glycerophosphate; the differentiation process is commonly evaluated by alkaline phosphatase activity, osteogenic marker expression, collagenous matrix formation, and calcium-rich matrix mineralization. The main readouts are alkaline phosphatase activity as an early osteogenic marker and Alizarin Red S staining as a calcium-deposit readout for mineralized extracellular matrix; Alizarin Red S can be inspected microscopically or extracted and measured colorimetrically at 405 nm.
-
Endothelial Tube Formation Assay
Endothelial tube formation assay evaluates the ability of endothelial cells to attach, migrate, align, and organize into capillary-like networks when cultured on gelled basement membrane extract or Matrigel; the readout is the morphology and quantity of tube-like networks, which reflects an in vitro endothelial morphogenesis step related to angiogenesis. Basement membrane extract/Matrigel provides laminin-rich extracellular matrix cues that support endothelial differentiation into capillary-like structures, but it can contain biologically active growth factors, so growth-factor-reduced matrix is preferred when testing defined angiogenic stimulators or inhibitors.
-
Research Protocol for Inflammation-related Diseases
The NLRP3 inflammasome is a cytosolic innate immune signaling platform that integrates priming signals and danger-signal activation to promote caspase-1 activation, maturation of IL-1β and IL-18, and gasdermin D-mediated pyroptotic cell death. The core experimental logic is to determine whether inflammatory disease phenotypes are driven by increased NLRP3 expression, ASC-containing inflammasome assembly, caspase-1 cleavage, GSDMD cleavage, and extracellular release of IL-1β/IL-18 rather than by nonspecific cell injury alone. The pathway is strongly linked to inflammation-related disease phenotypes because monosodium urate crystals activate NALP3/NLRP3 inflammasome signaling in gout-like crystal inflammation, cholesterol crystals activate NLRP3 inflammasomes in atherogenesis models, and DSS-induced intestinal inflammation has been reported to involve NLRP3 inflammasome activity. However, experimental colitis studies also show context-dependent protective effects of NLRP3 inflammasome co
-
Endothelial Cell Migration/Angiogenic Sprouting Assay
Endothelial cell migration and angiogenic sprouting assays are in vitro (and partially ex vivo-adapted) functional models that quantify the ability of endothelial cells to undergo coordinated migration, extracellular matrix invasion, and multicellular organization into capillary-like sprouts in response to pro-angiogenic stimuli such as VEGF, bFGF, or conditioned microenvironments. These assays are used to model early angiogenic events including tip-cell formation, directional migration, and lumen-like sprout extension, which collectively reflect angiogenic activation and vascular morphogenesis processes observed in vivo.
Purity & Documentation
-
Data Sheet (279 KB)
-
SDS (557 KB)
- English - EN (557 KB)
- Français - FR (557 KB)
- Deutsch - DE (557 KB)
- Norwegian - NO (557 KB)
- Español - ES (557 KB)
- Swedish - SV (557 KB)
- Italian - IT (557 KB)
- Korean - KR (557 KB)
- Portuguese - PT (557 KB)
-
Handling Instructions (2659 KB)
References
[2]. Maxim LD, et al. A review of the toxicology and epidemiology of wollastonite. Inhalation toxicology. 2005 Aug;17(9):451-66. [Content Brief]
[3]. Zenebe CG, et al. A Review on the Role of Wollastonite Biomaterial in Bone Tissue Engineering. BioMed research international. 2022;2022:4996530. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- Wollastonite
- 13983-17-0
- Biochemical Assay Reagents
- Drug Intermediate
- Reactive Oxygen Species (ROS)
- mesothelial cell
- poly(3-hydroxybutyrate-co-3-hydroxy valerate)
- hydroxycarbonate apatite
- PMN leukocyte
- alveolar macrophage
- rabbit alveolar macrophages
- red blood cells
- hydroxyapatite
- reactive oxygen species
- human mesenchymal stem cells
- Inhibitor
- inhibitor
- inhibit